As of 2024-12-12, the Relative Valuation of AstraZeneca PLC (AZN.L) is 7,273.23 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 10,538.00 GBP, the upside of AstraZeneca PLC based on Relative Valuation is -31.0%.
The range of the Relative Valuation is 5,574.03 - 8,715.84 GBP.
| Range | Selected | |
| Trailing P/E multiples | 17.0x - 24.9x | 21.2x |
| Forward P/E multiples | 21.2x - 26.7x | 23.4x |
| Fair Price | 5,574.03 - 8,715.84 | 7,273.23 |
| Upside | -47.1% - -17.3% | -31.0% |
| Date | P/E |
| 2024-12-12 | 32.20 |
| 2024-12-11 | 32.22 |
| 2024-12-10 | 32.14 |
| 2024-12-09 | 32.72 |
| 2024-12-06 | 32.57 |
| 2024-12-05 | 32.46 |
| 2024-12-04 | 32.04 |
| 2024-12-03 | 32.99 |
| 2024-12-02 | 32.26 |
| 2024-11-29 | 32.44 |
| 2024-11-28 | 32.39 |
| 2024-11-27 | 32.20 |
| 2024-11-26 | 32.07 |
| 2024-11-25 | 32.02 |
| 2024-11-22 | 32.02 |
| 2024-11-21 | 30.76 |
| 2024-11-20 | 30.48 |
| 2024-11-19 | 30.64 |
| 2024-11-18 | 30.31 |
| 2024-11-15 | 30.50 |
| 2024-11-14 | 31.46 |
| 2024-11-13 | 31.01 |
| 2024-11-12 | 30.54 |
| 2024-11-11 | 30.52 |
| 2024-11-08 | 30.27 |
| 2024-11-07 | 29.73 |
| 2024-11-06 | 30.33 |
| 2024-11-05 | 30.92 |
| 2024-11-04 | 33.76 |
| 2024-11-01 | 33.69 |
| 2024-10-31 | 33.76 |
| 2024-10-30 | 34.26 |
| 2024-10-29 | 35.26 |
| 2024-10-28 | 35.55 |
| 2024-10-25 | 35.48 |
| 2024-10-24 | 35.76 |
| 2024-10-23 | 36.16 |
| 2024-10-22 | 36.27 |
| 2024-10-21 | 36.47 |
| 2024-10-18 | 36.52 |
| 2024-10-17 | 36.76 |
| 2024-10-16 | 36.76 |
| 2024-10-15 | 36.23 |
| 2024-10-14 | 36.49 |
| 2024-10-11 | 35.96 |
| 2024-10-10 | 35.98 |
| 2024-10-09 | 35.94 |
| 2024-10-08 | 35.70 |
| 2024-10-07 | 36.10 |
| 2024-10-04 | 35.88 |